Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

683 studies match

clinicaltrialsPublishedShowing 1–50 of 683 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05038735	Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.(EPIK-B5)	active not recruiting	Phase 3	210	Novartis PharmaceuticalsINDUSTRY	17	Sep 29, 2026	clinicaltrials
NCT05132582	A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer(HER2CLIMB-05)	active not recruiting	Phase 3	654	Seagen, a wholly owned subsidiary of Pfizer